Ann: Rhythm Maintains Ongoing ISO13485 Certification, page-22

RHY Announcement extract - April 2, 2020

“Despite the current macroeconomic climate, I would remind all stakeholders that in addition
to potentially replacing or working as an adjunct< of the current faecal testing, the ColoSTAT®
test kit will enable the reading of cancerous samples, rather than just the presence of blood
in faeces. More so, we believe a simple blood test should improve the current poor compliance
record of the faecal immunochemical test (FIT), saving lives and healthcare costs globally,”
said Mr Gilbert.
“We strongly believe ColoSTAT® has a global market, whereby the ColoSTAT® test could be
added to the standard panel of blood tests a GP may run for their patients as part of their
annual check-up. Further, once approved, ColoSTAT® has the potential to attract
reimbursement by both governments and health insurance companies worldwide” Mr Gilbert
said.